MSU expert: What to know about flu, RSV, new COVID-19 variant and new vaccine

The new COVID-19 EG.5 variant is responsible for around 22% of current cases. The World Health Organization has classified it as a “variant of interest,” meaning countries should monitor it more closely than other strains — and cases have only increased in the past few weeks. Peter Gulick is an expert on infectious diseases, and he provides insight on what this new variant could mean and what you should know.

Initiative to Strengthen Response to Infectious Disease Outbreaks in the Mountain West

The COVID-19 pandemic spotlighted how a rapid and effective response to infectious disease outbreaks is critical for saving lives and protecting communities. With a $17.5 million, five-year grant from the U.S. Centers for Disease Control and Prevention (CDC), University of Utah researchers, in collaboration with Washington State University, are leading efforts to provide data and tools that guide decisions to improve responses to emerging public health threats in the Mountain West.

Katalin Karikó and Drew Weissman, Penn’s Historic mRNA Vaccine Research Team, Win 2023 Nobel Prize in Medicine

PHILADELPHIA – The University of Pennsylvania messenger RNA pioneers whose years of scientific partnership unlocked understanding of how to modify mRNA to make it an effective therapeutic—enabling a platform used to rapidly develop lifesaving vaccines amid the global COVID-19 pandemic—have been named winners of the 2023 Nobel Prize in Physiology or Medicine.

Rutgers Experts on School Climate and Conditions for Learning Available to Comment on Post-COVID Educational Challenges

Dr. Alicia Raia-Hawrylak, Co-Project Manager for the School Climate Transformation Project (SCTP), is available to comment on post-COVID concerns related to school climate, including student behavior and bullying, social and emotional learning, staff retention, and using data to guide the…

The Latest in Science and Medical Advancement in Otolaryngology-Head and Neck Surgery to be Presented at AAO-HNSF Annual Meeting

The latest research and advances in otolaryngology-head and neck surgery will be presented in Nashville, Tennessee, during the AAO-HNSF 2023 Annual Meeting & OTO Experience, September 30 – October 4.

Global background rates study analyzes data from 197 million people for assessment of COVID-19 vaccine safety

The US CDC (Centers for Disease Control and Prevention) funded Global COVID Vaccine Safety Project has generated background incidence rates on a range of conditions designated as AESI (Adverse Events of Special Interest) for COVID-19 vaccine safety monitoring. Conditions studied included myocarditis, pulmonary embolism, and Guillain-Barré syndrome.

ACP issues updated Rapid, Living Practice Points on treating COVID-19 patients in outpatient settings

In an updated rapid, living practice points, the American College of Physicians (ACP) summarizes the latest evidence on the use of pharmacologic and biologic treatments of COVID-19 in the outpatient setting, specifically addressing the dominant severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant. The paper is published in Annals of Internal Medicine

Getting vaccines for flu, RSV, pneumonia and COVID.

David Winter, MD, at Baylor Scott & White Health, answers the most common patient questions and reacts to the latest medical research. With flu season approaching, who should get a flu shot and when? (SOT@ :14, TRT :24) RSV cases…

The Future of Medicine Rises in University City: University of Pennsylvania Opens New Multi-Disciplinary Research Labs in One uCity Square

Wexford Science & Technology, LLC and the University of Pennsylvania today announced that the University has signed a lease for new laboratory space that will usher in a wave of novel vaccine, therapeutics and engineered diagnostics research to West Philadelphia.

Clinical Labs’ Quick Response to COVID-19 Helped Reduce Hospitalizations and Save Lives

A new survey from the Association for Diagnostics & Laboratory Medicine (formerly AACC) found that clinical labs’ robust, rapid response to the COVID-19 pandemic helped to contain the virus and save lives. However, the challenges labs faced with insufficient supplies and staffing shortages have only intensified since 2020. The percentage of laboratory professionals reporting staffing issues rose steadily from 35.4% in May 2020 to 87.5% in January 2022—raising questions about whether labs would have the necessary resources to respond to a similar public health emergency today.

Dr. Carol Nwelue discusses how to keep your kids healthy when going back to school.

Carol Nwelue, MD, at Baylor Scott & White Health, answers common patient questions and reacts to the latest medical research. How can parents keep their kids healthy this back-to-school season? (SOT@ 0:14, TRT 0:34) Why do sicknesses spread easily when…

Rather than providing protection, an Omicron infection may leave patients more susceptible to future COVID infections, researchers find after studying seniors in care

Researchers at McMaster University have found that rather than conferring immunity against future infections, infection during the first Omicron wave of COVID left the seniors they studied much more vulnerable to reinfection during the second Omicron wave.

Long-Term Study Reaffirms Benefits of Covid-19 Vaccination for Organ Transplant Recipients

A two-year study found that spikes of post-vaccination SARS-CoV-2 viral infections (commonly known as COVID-19 breakthrough cases) remain common, yet hospitalization rates have dramatically dropped following the first wave of the virus’ omicron subvariant.

Dr. Marc Elieson discusses concerns about COVID-19 and kids going back to school

Marc Elieson, MD, at Baylor Scott & White Health, answers common patient questions and reacts to the latest medical research. The CDC says COVID cases will continue to increase this summer and when school resumes this fall. What is behind…

International Study Shows that Taste, Independent of Smell, Can Also be Significantly Diminished in Patients with COVID-19

Smell loss became the cardinal symptom of COVID-19 early in the pandemic and has ignited research on how smell and taste function. An international study led by the Global Consortium for Chemosensory Research (GCCR) and the Monell Chemical Senses Center has untied taste from smell in people with COVID-19, demonstrating in a large and diverse group of more than 10,000 people that taste, independent of smell, is also greatly impacted by COVID.

More Than 2 Million Additional Americans Faced Food Insufficiency Following Drawdown of Pandemic-Related SNAP Benefits, Penn Medicine Study Finds

The recent discontinuation of pandemic-related food assistance benefits, known as the Supplemental Food Assistance Program (SNAP) Emergency Allotments, led to a substantial increase in food insufficiency in the United States, according to a new study led by researchers at the Perelman School of Medicine at the University of Pennsylvania.

Study Reveals Patients Hospitalized with COVID-19 Faced Nearly Twice the Rates of Death After Discharge As Patients with Flu

Researchers demonstrate that among individuals who were admitted to the hospital with COVID-19 and were discharged alive, the risk of post-discharge death was nearly twice that observed in those who were discharged alive from an influenza-related hospital admission.

Early-Stage Cancer Diagnoses Decreased Sharply in the U.S. During First Year of COVID-19 Pandemic; Underserved Greatly Affected

A new study from researchers at the American Cancer Society found monthly adult cancer diagnoses decreased by half in April 2020 during the COVID-19 pandemic in the United States. The largest decrease was for stage I cancers, resulting in a higher proportion of late-stage diagnoses.

ACP Says the U.S. Needs Immediate Action to Prepare for Future Pandemics

The United States has significant gaps in its pandemic and public health emergency response system leaving it unprepared for future emergencies, says the American College of Physicians (ACP) in a new policy paper. In the paper, ACP makes recommendations about what needs to be done to ensure the U.S. is in a strong position to mitigate the consequences of future pandemics. The paper is published in Annals of Internal Medicine.

Promising Results of Next-Generation Intranasal COVID-19 Booster Vaccine: Implications for Infection Prevention and Transmission

The Icahn School of Medicine at Mount Sinai in New York, NY is pleased to announce that CastleVax, Inc. has completed enrollment and a preliminary analysis of a phase 1 trial of its licensed Newcastle disease virus (NDV)-based COVID-19 booster vaccine.

Gene Mutation May Explain Why Some Don’t Get Sick from COVID-19

People who contract COVID-19 but never develop symptoms – the so-called super dodgers – may have a genetic ace up their sleeve. They’re more than twice as likely as those who become symptomatic to carry a specific gene variation that helps them obliterate the virus, according to a new study led by UC San Francisco researchers.